Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective

Without stringent criteria, liver transplantation for hepatocellular carcinoma (HCC) can lead to high cancer recurrence and poor prognosis in the current treatment context. Checkpoint inhibitors can lead to long survival by targeting coinhibitory pathways and promoting T-cell activity; thus, they ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ho, Cheng-Maw, Chen, Hui-Ling, Hu, Rey-Heng, Lee, Po-Huang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487770/
https://www.ncbi.nlm.nih.gov/pubmed/31065295
http://dx.doi.org/10.1177/1758835919843463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487770/
https://www.ncbi.nlm.nih.gov/pubmed/31065295
http://dx.doi.org/10.1177/1758835919843463

Ejemplares similares